Resmed buys VirtuOx

SAN DIEGO – Resmed has acquired VirtuOx, an independent diagnostic testing facility (IDTF) for sleep, respiratory and cardiac conditions. 

With VirtuOx’s at-home diagnostic services, Resmed says it will be better positioned to support patients earlier in their journey and help health care providers and home care companies deliver care. 

“This is about creating a simpler, more connected pathway to care,” said Justin Leong, chief product officer at Resmed. “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnea and related conditions.” 

VirtuOx will operate as a fully owned subsidiary of Resmed, continuing to serve partners and patients under its existing brand in the near term. The company’s leadership team will also remain in place. 

The acquisition strengthens Resmed’s ability to partner with health care providers to help streamline the diagnostic process and alleviate current bottlenecks, while expanding collaboration with home medical equipment providers to efficiently and expeditiously support patients to start treatment. It further enhances the company’s ability to serve health care providers with integrated tools that improve care coordination, patient engagement and outcomes. 

“VirtuOx and Resmed are aligned in our focus to simplify health care and expand access,” said Steve Lica, CEO of VirtuOx. “Joining Resmed gives us the opportunity to scale our impact, reach and help more patients, and keep innovating on behalf of the providers and health systems we serve.” 

Financial terms are not being disclosed, as the acquisition is not material to Resmed’s financial results.